Market Overview

The Global RNA Analysis Market was valued at USD 10,832.6 million in 2023 and is expected to reach USD 25,878.0 million by 2031 while growing at a CAGR of 11.5% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global RNA analysis market growth. RNA analysis delves into the examination of RNA molecules within biological samples, comprehending their structure, function, abundance, and regulation. As a pivotal molecule in cellular processes such as gene expression, protein synthesis, and gene activity regulation, RNA (ribonucleic acid) plays a crucial role.

The continuous advancements in transcriptomics technologies, including RNA sequencing (RNA-Seq), single-cell RNA sequencing (scRNA-Seq), and droplet-based RNA sequencing, propel the growth of the RNA analysis market, while Standardization and Quality Control Challenges, as well as Ethical and Privacy Concerns, pose obstacles to its expansion.

Furthermore, the global RNA analysis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Analysis

The Global RNA Analysis Market is segmented among Instruments, Kits & Reagents, and Services, based on Product. In 2023, Kits & Reagents accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Technology Analysis

The Global RNA Analysis Market is segmented among Real Time-PCR (qPCR), Microarray, Sequencing, and Others, based on Technology. In 2023, Real Time-PCR (qPCR) accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global RNA Analysis Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., QIAGEN, Thermo Fisher Scientific, Inc., Eurofins Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Pacific Bioscience of California, Inc., Affymetrix, Inc., Danaher, and Promega.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global RNA Analysis Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global RNA Analysis Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global RNA Analysis Market Segmentation, By Product

• Global RNA Analysis Market Share Analysis, By Product

• Global RNA Analysis Market Growth Analysis, By Product

• Global RNA Analysis Market Trends, By Product

o Instruments

o Kits & Reagents

Ø miRNA & siRNA

Ø Reverse Transcriptases & RT-PCR

Ø RNA Extraction & Purification

Ø RNA Interference

Ø Others

o Services

6. Global RNA Analysis Market Segmentation, By Technology

• Global RNA Analysis Market Share Analysis, By Technology

• Global RNA Analysis Market Growth Analysis, By Technology

• Global RNA Analysis Market Trends, By Technology

o Real Time-PCR (qPCR)

o Microarray

o Sequencing

o Others

7. Global RNA Analysis Market Segmentation, By Application

• Global RNA Analysis Market Share Analysis, By Application

• Global RNA Analysis Market Growth Analysis, By Application

• Global RNA Analysis Market Trends, By Application

o Construction of RNA Expression Atlas

o Epigenetics

o Infectious Diseases & Pathogenesis

o Alternative RNA Splicing

o RNA Structure & Molecular Dynamics

o Development & Delivery of RNA Therapeutics

o Others

8. Global RNA Analysis Market Segmentation, By End Use

• Global RNA Analysis Market Share Analysis, By End Use

• Global RNA Analysis Market Growth Analysis, By End Use

• Global RNA Analysis Market Trends, By End Use

o Government Institutes & Academic Centers

o Pharmaceutical & Biotechnology Companies

o Hospitals & Clinics

o Contract Research Organizations (CROs)

9. Global RNA Analysis Market Segmentation, By Region

• Global RNA Analysis Market Share Analysis, By Region

• Global RNA Analysis Market Growth Analysis, By Region

• Global RNA Analysis Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

• Agilent Technologies, Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• F. Hoffmann-La Roche AG

• Illumina, Inc.

• QIAGEN

• Thermo Fisher Scientific, Inc.

• Eurofins Scientific

• Merck KGaA

• Bio-Rad Laboratories, Inc.

• Pacific Bioscience of California, Inc.

• Affymetrix, Inc.

• Danaher

• Promega Corporation

*Similar analysis will be provided for each company listed above.